We are live on
!
Find out more
KA
Kovack Advisors Portfolio holdings
AUM
$2.08B
1-Year Est. Return
38.95%
This Fund
S&P 500
This Quarter
Est. Return
+0.13%
1 Year Est. Return
+38.95%
3 Year Est. Return
+118.27%
5 Year Est. Return
+142.08%
10 Year Est. Return
+472.03%
AUM
$920M
AUM Growth
+$41.6M
(+4.7%)
Cap. Flow
+$50.7M
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
21.24%
Holding
787
New
83
Increased
356
Reduced
204
Closed
80
Avg Time Held Equity + Options
8.3
quarters
Top 10 Avg Time Held Equity + Options
12.2
quarters
Top 20 Avg Time Held Equity + Options
9.3
quarters
Avg Time Held Equity only
8.5
quarters
Top 10 Avg Time Held Equity only
12.2
quarters
Top 20 Avg Time Held Equity only
9.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.06M |
| 2 |
ProShares Short S&P500
SH
|
+$2.16M |
| 3 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$2.12M |
| 4 |
Amazon
AMZN
|
+$1.99M |
| 5 |
Apple
AAPL
|
+$1.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$1.51M |
| 2 |
Adtran
ADTN
|
+$1.38M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.22M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$1.03M |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.29% |
| 2 | Technology | 19.78% |
| 3 | Consumer Discretionary | 8.37% |
| 4 | Financials | 5.38% |
| 5 | Healthcare | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Eli Lilly
LLY
$1.05T
| $951K | 0.1% |
4,117
-67
| -2% | -$16.5K |
2018 Q3
12 quarters
|
|
227
Atlassian
TEAM
$52.6B
| $946K | 0.1% |
2,416
-4
| -0.2% | -$1.34K |
2019 Q2
9 quarters
|
|
228
Nike
NKE
$52.5B
| $936K | 0.1% |
6,443
+2,274
| +55% | +$371K |
2016 Q2
21 quarters
|
|
229
Gilead Sciences
GILD
$187B
| $929K | 0.1% |
13,294
+6,667
| +101% | +$468K |
2016 Q4
19 quarters
|
|
230
Invesco BuyBack Achievers ETF
PKW
$1.71B
| $926K | 0.1% |
10,275
+753
| +8% | +$69.3K |
2021 Q2
1 quarter
|
|
231
Vanguard Extended Market ETF
VXF
$30.4B
| $922K | 0.1% |
5,056
+92
| +2% | +$17.2K |
2016 Q4
19 quarters
|
|
232
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $905K | 0.1% |
16,978
+1,036
| +6% | +$55.4K |
2017 Q3
16 quarters
|
|
233
Wells Fargo
WFC
$252B
| $903K | 0.1% |
19,458
+2,113
| +12% | +$97.8K |
2020 Q2
5 quarters
|
|
234
3M
MMM
$83B
| $901K | 0.1% |
6,141
+39
| +0.6% | +$6.32K |
2016 Q1
22 quarters
|
|
235
Regeneron Pharmaceuticals
REGN
$78.5B
| $896K | 0.1% |
1,481
+1,086
| +275% | +$674K |
2021 Q2
1 quarter
|
|
|
COUP
236
DELISTED
Coupa Software Incorporated
COUP
| $896K | 0.1% |
4,086
-233
| -5% | -$54.7K |
2020 Q3
4 quarters
|
|
237
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.8B
| $887K | 0.1% |
14,763
+109
| +0.7% | +$6.62K |
2019 Q2
9 quarters
|
|
238
Jones Lang LaSalle
JLL
$13.7B
| $887K | 0.1% |
+3,575
| New | +$816K |
2021 Q3
0 quarters
|
|
239
DELISTED
Emcore Corp
EMKR
| $887K | 0.1% |
11,860
+210
| +2% | +$16.8K |
2020 Q4
3 quarters
|
|
240
Medtronic
MDT
$118B
| $883K | 0.1% |
7,045
-21
| -0.3% | -$2.72K |
2017 Q4
15 quarters
|
|
241
iShares Gold Trust
IAU
$61.8B
| $880K | 0.1% |
26,328
-2,349
| -8% | -$80K |
2015 Q4
23 quarters
|
|
242
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $879K | 0.1% |
6,298
+30
| +0.5% | +$4.26K |
2015 Q4
23 quarters
|
|
243
Compass Minerals
CMP
$961M
| $873K | 0.09% |
13,556
+1
| +0% | +$66 |
2020 Q3
4 quarters
|
|
244
ProShares Short Russell2000
RWM
$142M
| $873K | 0.09% |
40,400
+5,000
| +14% | +$108K |
2021 Q1
2 quarters
|
|
245
Vanguard High Dividend Yield ETF
VYM
$81B
| $870K | 0.09% |
8,414
+179
| +2% | +$18.9K |
2016 Q3
20 quarters
|
|
246
General Mills
GIS
$17.5B
| $868K | 0.09% |
14,509
-150
| -1% | -$8.86K |
2017 Q2
17 quarters
|
|
247
VanEck Preferred Securities ex Financials ETF
PFXF
$2.32B
| $868K | 0.09% |
40,884
+11,816
| +41% | +$254K |
2020 Q4
3 quarters
|
|
248
Target
TGT
$69.8B
| $866K | 0.09% |
3,785
+8
| +0.2% | +$2K |
2019 Q1
10 quarters
|
|
249
Invesco Value Municipal Income Trust
IIM
$503M
| $862K | 0.09% |
52,828
+3
| +0% | +$51 |
2018 Q4
11 quarters
|
|
250
Vanguard Health Care ETF
VHT
$19.4B
| $860K | 0.09% |
3,481
+305
| +10% | +$78.2K |
2019 Q3
8 quarters
|
|
Similar funds
TA
NCMU
ICM
CAM
TFS
OPAM
WFMPM
OAM
Kovack Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Kovack Advisors held 787 positions worth $920M, up 4.7% from $879M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Kovack Advisors deployed $50.7M of net new capital in Q3 2021, opening 83 new positions and adding to 356 existing holdings. Its largest new stake was ProShares Short S&P500: 36,318 shares worth $2.21M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Idexx Laboratories, an estimated $1.51M trimmed.
- Kovack Advisors's largest Q3 2021 buy was ProShares Short S&P500: 36,318 shares worth $2.21M.
- Kovack Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $8.06M increase.
- Kovack Advisors's biggest Q3 2021 reduction was Idexx Laboratories, cutting an estimated $1.51M.
- Kovack Advisors fully exited abrdn Physical Precious Metals Basket Shares ETF in Q3 2021, selling an estimated $839K.
- Kovack Advisors's ten largest holdings make up 21% of its $920M portfolio in Q3 2021.
- Kovack Advisors opened 83 new positions and closed 80 in Q3 2021.
- Kovack Advisors's portfolio value rose 4.7% quarter-over-quarter to $920M.
Based on Kovack Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.